Literature DB >> 9317146

Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10.

N Duque1, C Gómez-Guerrero, J Egido.   

Abstract

The mechanisms of glomerular damage in IgA nephropathy remain undefined. Mesangial cells (MC) possess Fc receptors for IgA (Fc alpha R), and their occupancy triggers cytokine expression, cell proliferation, and extracellular matrix synthesis. In cultured human MC we examined the effects of soluble IgA aggregates (AIgA) on the activation of nuclear factor-kappa B (NF-kappa B) and the production of proinflammatory chemokines monocyte chemoattractant protein-1 (MCP-1), IL-8, and IFN-inducible protein-10 (IP-10). The exposure of MC to AIgA rapidly activated a NF-kappa B complex constituted of p50 and p65 subunits. NF-kappa B activation was dose dependent, abolished by preincubation with IgA Fc fragments (indicating that AIgA effects occur via specific Fc alpha R), and attenuated by kinase inhibitors. MC stimulation with AIgA increased the mRNA expression of MCP-1, IL-8, and IP-10 in a time- and dose-dependent manner. Maximal expression of IL-8 was observed at 3 h (4.5-fold), while IP-10 and MCP-1 peaked at 6 h (5-fold for both). AIgA also induced biosynthesis and release of the chemokines, which presented biological activity in neutrophil and monocyte chemoattractant assays, peaking at 6 and 9 h, respectively. MC pretreatment with the antioxidant pyrrolidine dithiocarbamate inhibited NF-kappa B activation and chemokine mRNA expression. This study shows that stimulation of Fc alphaR in MC induces gene expression of MCP-1, IL-8, and IP-10, a process partially mediated by NF-kappa B activation. These data may be of importance for a better understanding of the pathogenesis of glomerular damage in IgA immune complex-related diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317146

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation.

Authors:  S R Chintalacharuvu; N U Nagy; N Sigmund; J G Nedrud; M E Amm; S N Emancipator
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 2.  Progress in molecular and genetic studies of IgA nephropathy.

Authors:  J Novak; B A Julian; M Tomana; J Mesteck
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

3.  In vitro-generated immune complexes containing galactose-deficient IgA1 stimulate proliferation of mesangial cells.

Authors:  Takeshi Yanagihara; Rhubell Brown; Stacy Hall; Zina Moldoveanu; Alice Goepfert; Milan Tomana; Bruce A Julian; Jiri Mestecky; Jan Novak
Journal:  Results Immunol       Date:  2012-01-01

4.  Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.

Authors:  Xuxiang Sheng; Xiaoyan Zuo; Xihui Liu; Yang Zhou; Xia Sun
Journal:  Int Urol Nephrol       Date:  2017-12-11       Impact factor: 2.370

5.  IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.

Authors:  Jan Novak; Leona Raskova Kafkova; Hitoshi Suzuki; Milan Tomana; Karel Matousovic; Rhubell Brown; Stacy Hall; John T Sanders; T Matthew Eison; Zina Moldoveanu; Lea Novak; Zdenek Novak; Richard Mayne; Bruce A Julian; Jiri Mestecky; Robert J Wyatt
Journal:  Nephrol Dial Transplant       Date:  2011-08-09       Impact factor: 5.992

6.  Association of C4d deposition with clinical outcomes in IgA nephropathy.

Authors:  Mario Espinosa; Rosa Ortega; Marina Sánchez; Alfons Segarra; Maria Teresa Salcedo; Fayna González; Rafael Camacho; Miguel Angel Valdivia; Rocio Cabrera; Katia López; Fernando Pinedo; Eduardo Gutierrez; Alfonso Valera; Miryam Leon; Maria Angeles Cobo; Rosa Rodriguez; Jose Ballarín; Yolanda Arce; Beatriz García; María Dolores Muñoz; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 8.237

7.  IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.

Authors:  Hitoshi Suzuki; Zina Moldoveanu; Stacy Hall; Rhubell Brown; Huong L Vu; Lea Novak; Bruce A Julian; Milan Tomana; Robert J Wyatt; Jeffrey C Edberg; Graciela S Alarcón; Robert P Kimberly; Yasuhiko Tomino; Jiri Mestecky; Jan Novak
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

8.  Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis.

Authors:  Oscar López-Franco; Yusuke Suzuki; Guillermo Sanjuán; Julia Blanco; Purificación Hernández-Vargas; Yoshikage Yo; Jeffrey Kopp; Jesús Egido; Carmen Gómez-Guerrero
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

9.  CXCR3 is involved in tubulointerstitial injury in human glomerulonephritis.

Authors:  Stephan Segerer; Bernhard Banas; Markus Wörnle; Holger Schmid; Clemens D Cohen; Matthias Kretzler; Matthias Mack; Eva Kiss; Peter J Nelson; Detlef Schlöndorff; Hermann-Josef Gröne
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

10.  Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets reveals switch from an inflammatory to steatotic transcriptional program.

Authors:  Marijana Radonjic; Jorn R de Haan; Marjan J van Erk; Ko Willems van Dijk; Sjoerd A A van den Berg; Philip J de Groot; Michael Müller; Ben van Ommen
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.